drugset / Trial / NCT00698334

Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis

NCT00698334

Non-randomizedParallel-groupOpen-labelTreatment

Summary

Tuberculosis (TB) is the most common opportunistic infection among HIV infected persons living in developing countries. Directly observed treatment, short-course (DOTS) is the internationally recommended strategy for the treatment of TB. However, the efficacy of DOTS for the treatment of HIV-associated TB is not well studied. This study aims to compare the efficacy of thrice weekly DOTS in HIV-infected versus HIV-negative patients with TB.

Timeline

Start
2006-04
Primary completion
2010-09
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ethambutol Small molecule 1200 mg
Comparator INH Unknown 600 mg
Comparator Pyrazinamide Small molecule 1500 mg
Comparator Rifampin Small molecule 450 mg
Comparator Rifampin Small molecule 600 mg

Indications